
A leading provider of
innovative DNA Screening solutions
Deletions of 22q11.2 are found in 90% of patients with DiGeorge Syndrome (DGS). However, alternative deletions on 10p13.14 have been shown in some patients with DGS. A gene within the 300Kb minimal region of DGS2, BRUNOL3, has been identified and is a candidate gene for the heart defect and thymus hypoplasia/aplasia in these patients.
To provide as complete a set of DiGeorge microdeletion probes as possible, Cytocell has developed a probe to detect the deletion of BRUNOL3 on 10p14 to add to its 22q probes, TUPLE1, N25 and TBX1.
Cat. No. LPU 015-S (5 tests)
Cat. No. LPU 015 (10 tests)
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &